Re-irradiation with VMAT for progressive brain metastases after previous whole brain radiation for radionecrosis risk avoidance. Marilena Theodorou, MD.

Slides:



Advertisements
Similar presentations
Oncology management of CNS tumours Neil Burnet University of Cambridge Department of Oncology & Oncology Centre, Addenbrookes Hospital ECRIC CNS study.
Advertisements

Multidisciplinary approaches on chest tumors Radiation Oncology Case Reports.
DEOEC Institute of Oncology Department of Radiotherapy.
Dos 741 Protocols & Studies in Rad Onc 2011 Charles Poole
Radiotherapy for Brain Tumours What do I need to know? Dr Matthew Foote Radiation Oncologist Princess Alexandra Hospital Queensland.
Stereotactic Body Radiation Therapy (SBRT): The optimal indication for operable tumors in inoperable patients D.Katsochi 1, S.Kosmidis 1, A.Fotopoulou.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Radiotherapy Planning for Esophageal Cancers Parag Sanghvi, MD, MSPH 9/12/07 Esophageal Cancer Tumor Board Part 1.
بسم الله الرحمن الرحيم و قل رب زدنى علماً ﴿و قل رب زدنى علماً﴾ صدق الله العظيم.
Intra-Operative Radiation Therapy for Treatment of Early Stage Breast Cancer: Short Term Results from a Single Institution Clinical Trial Using Electronic.
Comparison of MRI Perfusion and PET-CT in Differentiating Brain Tumor Progression from Radiation Injury after Cranial Irradiation T. Jonathan Yang, M.D.
Conformal Therapy for Lung Cancer B. Schicker, F.J. Schwab*, U. Götz Institute of Radiotherapy and Radiation Oncology St. Vincenz-Krankenhaus Limburg *Clinic.
Vertebral Fractures After Stereotactic Ablative Radiotherapy of Lung Tumors Todd A. Aguilera MD PhD 1, Nicholas Trakul MD PhD 2, David B. Shultz MD PhD.
Comparison of Rectal Dose Volume Histograms for Definitive Prostate Radiotherapy Among Stereotactic Radiotherapy, IMRT, and 3D-CRT Techniques Author(s):
Proton Therapy for Chondrosarcomas of the Skull Base and Cervical Spine: Long-term Experience at Loma Linda University Medical Center D. Y. Kim 2, R. W.
1 Overview of Gamma Knife ® Surgery Dr. Sandra Vermeulen, M.D. Swedish Cancer Institute Northwest Hospital Gamma Knife Center Seattle, Washington Learn.
Department of Radiation Oncology University of Michigan Volumetric Arc treatment planning in the brain using synthetic CT images James M. Balter, Shu-Hui.
Laurie Cuttino MD, Dorin Todor PhD, Douglas Arthur MD, Rohini George, Lynn Pacyna CMD Medical College of Virginia Campus Department of Radiation Oncology.
Jacqulyn Barnes HBCU-UP Program Reading/Writing Segment Summer 2008.
Conflict of Interest Declaration: Nothing to Disclose Presenter: Sophie Lamoureux Title of Presentation: A Comparison of Stereotactic Body Radiotherapy.
SRS for spinal metastases. Who needs surgical stabilization?
Gamma Knife Kelly & Tarah.
Taipei VGH Practice Guidelines: Oncology Guidelines Index Cancer of Oral Cavity Version Table of Content StagingStaging, Manuscript Taipei Veterans.
Saad El Din I, M.D *, Abd El AAl H, M.D *, Makaar W, M.D *, El Beih D, M.Sc †, Hashem W, M.Sc * *Department of Clinical Oncology and Radiotherapy, Kasr.
Role of Radiation Therapy in Brain metastasis Bongkot Supawongwattana, M.D. Division of Therapeutic Radiology and Oncology, Faculty of Medicine, Chiang.
Head & Neck Ca. (Epithelial tumors) Mohamad KADRI. MD. Clinical oncology. Medical director of AlBerouni University Hospital President of Syrian Association.
第三讲: Basic treatment planning - Dengsong Zhu, MS, DABR Medical Physicist Radiation Safety Officer.
SARC018: A SARC PILOT MULTICENTER STUDY OF PREOPERATIVE RADIATION AND SURGERY IN PATIENTS WITH HIGH- RISK DESMOID TUMORS Robert S. Benjamin, M.D.
 Multidisciplinary Effort › Surgery › Radiation › Systemic Rx (chemo, “drugs”)
Authors: Syed H. Jafri ¹, Angel I. Blanco¹, Bonnie A. Labdi², Shan Guo¹. UT Houston department of medicine, Division of Oncology Department of Pharmacy.
Pencil Beam Scanning Proton Therapy for Lymphoma Patients with Mediastinal Involvement: A Dosimetric Study and Preliminary Clinical Data K. Dedeckova 1,
Image Guided Interstitial Brachytherapy For Locally Advanced Gynaecological Cancer With A MUPIT Applicator M.A.D. Haverkort, MD 1, E. Van der Steen - Banasik,
방사선종양학과 - 혈액종양내과 Joint Conference 경희의료원 방사선종양학과 R4 공 문 규.
Taipei Veterans General Hospital Practices Guidelines Oncology Oral Cavity Cancer Version
Dr. Malhar Patel DNB (Radiation Oncology)
cyberknife®: can we cure pancreatic cancer?
RCR breast radiotherapy consensus guidelines
Nasopharyngeal carcinoma
Neuroaxis Radiation for pediatric tumors (Medulloblastoma and Atypical teratoid/rhabdoid tumor) with VMAT (volumetric modulated arc therapy) and IMRT (intensity.
Dirk Vordermark, M. D. , Georg Becker, M. D. , Michael Flentje, M. D
Bladder Cancer and Prostatic Cancer
Extending intracranial treatment options with Leksell Gamma Knife® Icon™ Key Statements from Customer Perspective by University Medical Centre Mannheim.
Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group  Joachim Yahalom,
Feasibility of hippocampal sparing radiation therapy for glioblastoma using helical Tomotherapy Dr Kamalram THIPPU JAYAPRAKASH1,2,3, Dr Raj JENA1,4 and.
BRAIN METASTASES.
Introduction Materials & Methods Results Conclusion
Image–Guided Radiation Therapy for Non–small Cell Lung Cancer
Leksell Gamma Knife® Icon™
Junliang Liu, M.D., M.Sc. Ph.D., FRCPC Assistant Professor
Left Posterior Superior Right Anterior Inferior
Fig. 4. Percentage of passing rate between clinical and 544 plans.
VMAT-technique (volumetric modulated arc therapy), IMRT-technique (intensity modulated radiotherapy) and 3D-conformal radiation for Lymphomas in Radiation.
Neuroaxis Radiation for pediatric tumors (Medulloblastoma and Atypical teratoid/rhabdoid tumor) with VMAT (volumetric modulated arc therapy) and IMRT (intensity.
Insert tables Insert graphs Insert figure
Median Volume (cc) of GTV Receiving Dose
Volumetric Modulated Arc Therapy (VMAT) versus Intensity Modulated Radiation Therapy (IMRT) for Anal Carcinoma Heather Ortega, BSRT(T), CMD, Kerry Hibbitts,
Dosimetry of Alternative Techniques for Accelerated Partial Breast Irradiation Hanh Pham, B.S, CMD, Thanh Nguyen, BS, Christina Henson, MD, Salahuddin.
Insert tables Insert graphs Insert figure
Radiation Oncology Department, Bank of Cyprus Oncology Center.
L. A. den Otter. , R. M. Anakotta. , M. Dieters. , C. T. Muijs. , S
CK RS for non-resectable pancreatic tumors
A Multi-Institutional Dosimetric Evaluation of Proton Versus Photon Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma F. Khan, B. Nguyen,
Image–Guided Radiation Therapy for Non–small Cell Lung Cancer
Case studies: VMAT and SIB (simultaneous integrated boost) in pediatric tumours, from clinical target definition to toxicity as treated in the Radiation.
Radiation Therapy for Prostate Cancer
Stereotactic Ablative Radiotherapy for Centrally Located Early Stage Non–Small-Cell Lung Cancer: What We Have Learned  Joe Y. Chang, MD, PhD, Andrea Bezjak,
Clinical Radiation Oncology NMT232 L 10
Surgical Management of Brain Metastases
Neoadjuvant Adjuvant Curative Palliative
Technical Advances of Radiation Therapy for Thymic Malignancies
Presentation transcript:

Re-irradiation with VMAT for progressive brain metastases after previous whole brain radiation for radionecrosis risk avoidance. Marilena Theodorou, MD 1, , Andriana Peratikou, MSc, DABR, 2 , Stefani Stefanou MSc,CSci, MIPEM, 2, , Lora Ioannou, MSc, CSci, MIPEM, 2,, Efthymiou Themos MSc, 2, Erato Stylianou MSc, 2,,Ali Vehbi Artikan MSc, DABR, 2 Aristotelis Giannos MSc 2, Kyriaki Michailidou, PhD, 4 Demetrios Andreopoulos, MD,PhD 1 1 Radiation Oncology Department, Bank of Cyprus Oncology Center, 2 Medical Physics Department, Bank of Cyprus Oncology Center, 3 Department of electron microscopy/molecular pathology and the Cyprus School of molecular medicine, the Cyprus Institute for Genetics and Neurology Contact: marilena.theodorou@bococ.org.cy Radiation Oncology and Radiodiagnostics, Bank of Cyprus Oncology Center, Nicosia, Cyprus , www.bococ.org.cy Introduction The risk of radionecrosis is a main problem in radiotherapy oncology, especially for re-irradiation of the brain. Whole brain radiotherapy is indicated for multiple brain metastases (3 or more lesions),whereas local radiotherapy such as radiosurgery or stereotactic fractionated radiotherapy is indicated for oligometastatic disease (1- 3 lesions). Many patients with multiple brain metastases from breast cancer are irradiated with whole brain radiotherapy. Local radiotherapy is indicated if there is further disease progression or new brain metastases. With the advances in radiotherapy oncology and the new radiotherapy techniques available, re-irradiation is possible with high dose to the target and reduced risk for the organs at risk, reducing the risk of radionecrosis. . Methods In September 2014, a 35-year old patient was diagnosed with metastatic breast cancer presenting multiple brain metastases. She received 30Gy in 10 fractions to the whole brain. In February 2017, 2,5 years later, the patient developed acute palsy in the left arm and disease progression in the brain with 5 metastases appearing on MRI in the following locations: 1.Right temporal parietal ca. 7mm 2.Right occipital central compress posterior Horn of lateral Ventricle ca. 2,5 cm 3. Right cerebellum peripheral ca. 9mm 4. Right parietal central lateral the biggest metastasis, ca. 1cm 5. Left temporal ca. 8mm 03/2017 she received external beam radiation using VMAT (volumetric rapid arc radiotherapy) with Cone-Beam-CT verification, receiving a total dose 45Gy in 15 fractions (daily dose 3Gy/fraction) for the five metastases separately using one isocentre. This dose corresponds to a biological effective dose (BED) of stereotactic radiotherapy for brain metastases. For clinical target definition, the MRI was fused with the planning CT. The GTV (gross tumor volume) included the macroscopic metastases separately and the CTV (clinical target volume) included the GTV + 5mm safe margin. Immobilization of the head occurred with stereotactic thermoplastic mask. In order to evaluate the total dose to the organs at risk from both treatments, the previous plan for the whole brain treatment from September 2014 was added with the new VMAT plan. Results The table below shows the dose received by the organs at risk from both treatments. All doses received were well within the tolerance levels as per Quantec. The treatment was well tolerated by the patient without significant side effects or complications and she could continue working at the supermarket during her treatment. The further FU did not give late side effects and the MRIs showed complete response for the 4 small metastases, and partial response with necrotic changes for the largest metastasis. The latest MRI showed no evidence of necrosis. B VMAT Plan for the 5 metastases after previous whole brain radiation OAR Dose received Brainstem Max. dose: 46Gy, Mean dose: 26Gy Optic chiasm Max. dose: 22Gy Right optic nerve Max. dose: 11Gy Left optic nerve Max. dose: 12Gy Right lens Max. dose: 5,8Gy, Mean dose: 5Gy Left lens Max. dose: 6,5Gy, Mean dose: 5,5Gy Right internal ear Max. dose:25,8Gy, mean dose: 19,8Gy Left internal ear Max. dose: 16,6Gy, mean dose: 16Gy Conclusion and summary VMAT-technique (volumetric modulated arc therapy) for Re-irradiation of the brain for progressive brain metastases after previous radiation specially whole brain radiotherapy is indicated due to the good safety for the organ at risk in order to avoid radionecrosis risk. DEGRO 2018, Leipzig